Lithium Controlled-Release and Extended-Release Tablets and NovoSeven RT
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-NovoSeven RT with MixPro injection
- Lithium Controlled-Release and Extended-Release Tablets-Novothyrox
- Lithium Controlled-Release and Extended-Release Tablets-Noxafil
- Lithium Controlled-Release and Extended-Release Tablets-Noxafil (Posaconazole Delayed-Release Tablets)
- Lithium Controlled-Release and Extended-Release Tablets-Noxafil (Posaconazole Injection)
- Lithium Controlled-Release and Extended-Release Tablets-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Lithium ER
- NovoSeven RT-Lithium Oral Solution
- NovoSeven RT-Lithium Salts
- NovoSeven RT-Lithium Syrup and Oral Solution
- NovoSeven RT-Lithobid
- NovoSeven RT-Lithostat